A role for K268 in V2R folding

FEBS Letters

Volumn 579, Issue 22, 2005, Pages 4985-4990

  Le Gouill, Christian ^a   Darden, Thomas ^b   Madziva, Michael T ^b   Birnbaumer, Mariel ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Ion pair formation; Receptor internalization; Receptor phosphorylation; Vasopressin receptor

Indexed keywords

LYSINE; LYSINE 268; UNCLASSIFIED DRUG; VASOPRESSIN V2 RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CODON; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ARGININE VASOPRESSIN; CELL LINE; HUMANS; LYSINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; PROTEIN FOLDING; RECEPTORS, VASOPRESSIN; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 24144441213     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.08.003     Document Type: Article

References (27)

1. S.F. Altschul, W. Gish, W. Miller, E.W. Myers, and D.J. Lipman Basic local alignment search tool J. Mol. Biol. 215 1990 403 410
2. J.A. Ballesteros, A.D. Jensen, G. Liapakis, S.G.F. Rasmussen, L. Shi, U. Gether, and J.A. Javitch Activation of the β2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6 J. Biol. Chem. 276 2001 29171 29177
3. Birnbaumer. L. and Birnbaumer M. (1995) Signal transduction by G proteins. Functional considerations, primary structures of the components involved, and structure-function relations. In: Signal Transduction Across Membranes, Handbook of Biomembranes (Shiniztky, M., Ed.), vol. 3, pp. 153-252, Balaban Publishers, Rehovoth, Israel.
4. s/adenylyl cyclase system Mol. Endocrinol. 8 1994 886 894
5. Birnbaumer, M. (1999) Vasopressin receptor mutations and nephrogenic diabetes insipidus. In: Archives of Medical Research: G Protein-coupled Receptors and G Proteins in Endocrine Disease (Conn, P.M. and Ulloa, A., Eds.), vol. 30, pp. 465-474.
6. J. Cherfils, and M. Chabre Activation of G-protein Gα subunits by receptors through Gα-Gβ and Gα-Gγ interactions Trends Biochem. Sci. 28 2003 13 17
7. J. Cherfils, and P. Chardin GEFs: structural basis for their activation of small GTP binding proteins Trends Biochem. Sci. 24 1999 306 311
8. iα Nature 363 1993 274 276
9. R.L. Dunbrack Jr., and F.E. Cohen Bayesian statistical analysis of protein side-chain rotamer preferences Protein Sci. 6 1997 1661 1681
10. I. Erlenbach, and J. Wess Molecular basis of V2 vasopressin receptor/Gs coupling selectivity J. Biol. Chem. 273 1998 26549 26558
11. N. Guex, and M.C. Peitsch Swiss-model and the Swiss-Pdb viewer: an environment for comparative protein modeling Electrophoresis 18 1997 2714 2723
12. H. Hamm How activated receptors couple to G proteins? Proc. Natl. Acad. Sci. USA 98 2001 4819 4821
13. G. Innamorati, H. Sadeghi, A.N. Eberle, and M. Birnbaumer Phosphorylation of the V2 vasopressin receptor J. Biol. Chem. 272 1997 2486 2492
14. G. Innamorati, H. Sadeghi, N.T. Tran, and M. Birnbaumer A serine cluster prevents recycling of V2 vasopressin receptor Proc. Natl. Acad. Sci. USA 95 1998 2222 2226
15. S.A. Laporte, W.E. Miller, K.M. Kim, and M.G. Caron Beta-Arrestin/AP-2 interaction in G protein-coupled receptor internalization: identification of a beta-arrestin binding site in beta 2-adaptin J. Biol. Chem. 277 2002 9247 9254
16. J. Liu, and J. Wess Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family J. Biol. Chem. 271 1996 8772 8778
17. H. Luthman, and G. Magnusson High efficiency polyoma DNA transfection of chloroquine treated cells Nucleic Acids Res. 11 1983 1295 1308
18. N.P. Martin, R.J. Lefkowitz, and S.K. Shenoy Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination J. Biol. Chem. 278 2003 45954 45959
19. D. Morin, N. Cotte, M.-N. Balestre, B. Mouillac, M. Manning, C. Breton, and C. Barberis The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permit discrimination between antagonists with partial agonist and inverse agonist activities FEBS Lett. 441 1998 470 475
20. A. Oksche, R. Schuelein, C. Rutz, U. Liebenhoff, J. Dickson, H. Mueller, W. Rascher, M. Birnbaumer, and W. Rosenthal Vasopressin V2 receptor mutants causing X-linked nephrogenic diabetes insipidus: analysis of expression, processing and function Mol. Pharmacol. 50 1996 820 828
21. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto, and M. Miyano Crystal structure of rhodopsin: a G protein coupled receptor Science 289 2000 739 745
22. K.L. Pierce, R.T. Premont, and R.J. Lefkowitz Seven-transmembrane receptors Nat. Rev. Mol. Cell Biol. 3 2002 639 650
23. R.T. Premont, J.A. Pitcher, and R.J. Lefkowitz Protein kinases that phosphorylate activated G protein-coupled receptors FASEB J. 9 1995 175 182
24. Y. Salomon, C. Londos, and M. Rodbell A highly sensitive adenylate cyclase assay Anal. Biochem. 58 1974 541 548
25. F. Sanger, S. Nicklen, and A.B. Coulson DNA sequencing with chain-terminating inhibitors Proc. Natl. Acad. Sci. USA 74 1977 5463 5467
26. J.D. Thompson, D.G. Higgins, and T.J. Gibson Clustal-W - Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position specific gap penalties and weight matrix choice Nucleic Acids Res. 22 1994 4673 4680
27. S.V. Wu, M. Yang, D. Avedian, M. Birnbaumer, and J.H. Walsh Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin Mol. Pharmacol. 55 1999 795 803